Initiation factor modifications in the preapoptotic phase

Cell Death and Differentiation

Volumn 12, Issue 6, 2005, Pages 571-584

  Morley, S J ^a   Coldwell, M J ^a   Clemens, M J ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; eIF2; eIF4E binding proteins; eIF4G

Indexed keywords

INITIATION FACTOR; INITIATION FACTOR 2; INITIATION FACTOR 3; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4F; INITIATION FACTOR 4G; MESSENGER RNA;

APOPTOSIS; CELL GROWTH; CELL TRANSFORMATION; GROWTH REGULATION; HUMAN; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; REVIEW; RNA TRANSLATION; TRANSLATION INITIATION; TRANSLATION REGULATION;

ANIMALS; APOPTOSIS; EUKARYOTIC INITIATION FACTORS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER;

EID: 20144365870     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401591     Document Type: Review

References (159)

1. Morley SJ (2001) The regulation of eIF4F during cell growth and cell death. Prog. Mol. Subcell. Biol. 27: 1-37
2. Clemens MJ, Bushell M, Jeffrey IW, Pain VM and Morley SJ (2000) Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. 7: 603-615
3. Hershey JWB and Merrick WC (2000) Pathway and mechanism of initiation of protein synthesis In Translational Control of Gene Expression Sonenberg N, Hershey JWB and Mathews MB (eds) (New York: Cold Spring Harbor Laboratory Press) pp. 33-88
4. Sonenberg N and Dever TE (2003) Eukaryotic translation initiation factors and regulators. Curr. Opin. Struct. Biol. 13: 56-63
5. Abbott CM and Proud CG (2004) Translation factors: in sickness and in health. Trends Biochem. Sci. 29: 25-31
6. Kaufman RJ (2004) Regulation of mRNA translation by protein folding in the endoplasmic reticulum. Trends Biochem. Sci. 29: 152-158
7. Marcotrigiano J, Gingras AC, Sonenberg N and Burley SK (1997) Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89: 951-961
8. Mader S, Lee H, Pause A and Sonenberg N (1995) The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15: 4990-4997
9. Marcotrigiano J, Gingras AC, Sonenberg N and Burley SK (1999) Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol. Cell 3: 707-716
10. Ptushkina M, von der Haar T, Karim MM, Hughes JM and McCarthy JE (1999) Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state. EMBO J. 18: 4068-4075
11. Pain VM (1996) Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236: 747-771
12. Dever TE (1999) Translation initiation: adept at adapting. Trends Biochem. Sci. 24: 398-403
13. Preiss T and Hentze MW (1999) From factors to mechanisms: translation and translational control in eukaryotes. Curr. Opin. Genet. Dev. 9: 515-521
14. Gingras AC, Raught B and Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68: 913-963
15. Gingras AC, Raught B and Sonenberg N (2001) Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27: 143-174
16. Raught B, Gingras AC and Sonenberg N (2000) Regulation of ribosomal recruitment in eukaryotes In Translational Control of Gene Expression Sonenberg N, Hershey JWB and Mathews MB (eds) (New York: Cold Spring Harbor Laboratory Press) pp. 245-293
17. Scheper GC, van Kollenburg B, Hu J, Luo Y, Goss DJ and Proud CG (2002) Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA. J. Biol. Chem. 277: 3303-3309
18. Rousseau D, Gingras AC, Pause A and Sonenberg N (1996) The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13: 2415-2420
19. Karim MM, Hughes JM, Warwicker J, Scheper GC, Proud CG and McCarthy JE (2001) A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1. J. Biol. Chem. 276: 20750-20757
20. Watkins SJ and Norbury CJ (2002) Translation initiation and its deregulation during tumorigenesis. Br. J. Cancer 86: 1023-1027
21. Clemens MJ (2004) Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23: 3180-3188
22. Topisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering SJ, Jordan CT and Borden KL (2003) Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis. Mol. Cell. Biol. 23: 8992-9002
23. Zimmer SG, DeBenedetti A and Graff JR (2000) Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res. 20: 1343-1351
24. Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB and Polunovsky VA (2003) Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release. J. Biol. Chem. 278: 3015-3022
25. Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Bitterman PB (1996) Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol. Cell. Biol. 16: 6573-6581
26. Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC and Bitterman PB (2000) Translational control of the antiapoptotic function of Ras. J. Biol. Chem. 275: 24776-24780
27. Marth JD, Overell RW, Meier KE, Krebs EG and Perlmutter RM (1988) Translational activation of the Ick proto-oncogene. Nature 332: 171-173
28. Carter PS, Jarquin-Pardo M and De Benedetti A (1999) Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5′UTR. Oncogene 18: 4326-4335
29. Tan A, Bitterman P, Sonenberg N, Peterson M and Polunovsky V (2000) Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1. Oncogene 19: 1437-1447
30. Chung J, Bachelder RE, Lipscomb EA, Shaw LM and Mercurio AM (2002) Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J. Cell Biol. 158: 165-174
31. Yoder-Hill J, Pause A, Sonenberg N and Merrick WC (1993) The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A. J. Biol. Chem. 268: 5566-5573
32. Williams-Hill DM, Duncan RF, Nielsen PJ and Tahara SM (1997) Differential expression of the murine eukaryotic translation initiation factor isogenes eIF4A(I) and eIF4A(II) is dependent upon cellular growth status. Arch. Biochem. Biophys. 338: 111-120
33. Weinstein DC, Honore E and Hemmati-Brivanlou A (1997) Epidermal induction and inhibition of neural fate by translation initiation factor 4AIII. Development 124: 4235-4242
34. de la Cruz J, Kressler D and Linder P (1999) Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem. Sci. 24: 192-198
35. Li Q, Imataka H, Morino S, Rogers Jr. GW, Richter-Cook NJ, Merrick WC and Sonenberg N (1999) Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII. Mol. Cell. Biol. 19: 7336-7346
36. Pause A, Methot N, Svitkin Y, Merrick WC and Sonenberg N (1994) Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 13: 1205-1215
37. Shibuya T, Tange TO, Sonenberg N and Moore MJ (2004) eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nat. Struct. Mol. Biol. 11: 346-351
38. Palacios IM, Gatfield D, St Johnston D and Izaurralde E (2004) An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature 427: 753-757
39. Chan CC, Dostie J, Diem MD, Feng W, Mann M, Rappsilber J and Dreyfuss G (2004) eIF4A3 is a novel component of the exon junction complex. RNA 10: 200-209
40. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC and Sonenberg N (1990) Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol. Cell. Biol. 10: 1134-1144
41. Altmann M, Blum S, Wilson TM and Trachsel H (1990) The 5′-leader sequence of tobacco mosaic virus RNA mediates initiation- factor-4E-independent, but still initiation-factor-4A-dependent translation in yeast extracts. Gene 91: 127-129
42. Merrick WC (1994) Eukaryotic protein synthesis: an in vitro analysis. Biochimie 76: 822-830
43. Methot N, Rom E, Olsen H and Sonenberg N (1997) The human homologue of the yeast Prt1 protein is an integral part of the eukaryotic initiation factor 3 complex and interacts with p170. J. Biol. Chem. 272: 1110-1116
44. Milburn SC, Hershey JW, Davies MV, Kelleher K and Kaufman RJ (1990) Cloning and expression of eukaryotic initiation factor 4B cDNA: sequence determination identifies a common RNA recognition motif. EMBO J. 9: 2783-2790
45. Methot N, Pause A, Hershey JW and Sonenberg N (1994) The translation initiation factor eIF-4B contains an RNA-binding region that is distinct and independent from its ribonucleoprotein consensus sequence. Mol. Cell. Biol. 14: 2307-2316
46. Naranda T, Strong WB, Menaya J, Fabbri BJ and Hershey JW (1994) Two structural domains of initiation factor eIF-4B are involved in binding to RNA. J. Biol. Chem. 269: 14465-14472
47. Richter-Cook NJ, Dever TE, Hensold JO and Merrick WC (1998) Purification and characterization of a new eukaryotic protein translation factor. Eukaryotic initiation factor 4H. J. Biol. Chem. 273: 7579-7587
48. Rogers Jr GW, Richter NJ and Merrick WC (1999) Biochemical and kinetic characterization of the RNA helicase activity of eukaryotic initiation factor 4A. J. Biol. Chem. 274: 12236-12244
49. Hentze MW (1997) eIF4G: a multipurpose ribosome adapter? Science 275: 500-501
50. Morley SJ, Curtis PS and Pain VM (1997) eIF4G: translation's mystery factor begins to yield its secrets. RNA 3: 1085-1104
51. Yan R, Rychlik W, Etchison D and Rhoads RE (1992) Amino acid sequence of the human protein synthesis initiation factor eIF-4 gamma. J. Biol. Chem. 267: 23226-23231
52. Imataka H, Gradi A and Sonenberg N (1998) A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J. 17: 7480-7489
53. Bradley CA, Padovan JC, Thompson TC, Benoit CA, Chait BT and Rhoads RE (2002) Mass spectrometric analysis of the N-terminus of translation initiation factor eIF4G-1 reveals novel isoforms. J. Biol. Chem. 277: 12559-12571
54. Byrd MP, Zamora M and Lloyd RE (2002) Generation of multiple isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons. Mol. Cell. Biol. 22: 4499-4511
55. McKendrick L, Thompson E, Ferreira J, Morley SJ and Lewis JD. (2001) Interaction of eukaryotic translation initiation factor 4G with the nuclear cap-binding complex provides a link between nuclear and cytoplasmic functions of the m(7) guanosine cap. Mol. Cell. Biol. 21: 3632-3641
56. Lejeune F, Ranganathan AC and Maquat LE (2004) eIF4G is required for the pioneer round of translation in mammalian cells. Nat. Struct. Mol. Biol. 11: 992-1000
57. Jacobson A and Peltz SW (1996) Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu. Rev. Biochem. 65: 693-739
58. Gallie DR (1996) Translational control of cellular and viral mRNAs. Plant Mol. Biol. 32: 145-158
59. Tarun Jr SZ, Wells SE, Deardorff JA and Sachs AB (1997) Translation initiation factor eIF4G mediates in vitro poly(A) tail-dependent translation. Proc. Natl. Acad. Sci. USA 94: 9046-9051
60. Sachs AB, Sarnow P and Hentze MW (1997) Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89: 831-838
61. Wickens M, Anderson P and Jackson RJ (1997) Life and death in the cytoplasm: messages from the 3′ end. Curr. Opin. Genet. Dev. 7: 220-232
62. Le H, Tanguay RL, Balasta ML, Wei CC, Browning KS, Metz AM, Goss DJ and Gallie DR (1997) Translation initiation factors eIF-iso4G and eIF-4B interact with the poly(A)-binding protein and increase its RNA binding activity. J. Biol. Chem. 272: 16247-16255
63. Wells SE, Hillner PE, Vale RD and Sachs AB (1998) Circularisation of mRNA by eukaryotic translation initiation factors. Mol. Cell 2: 135-140
64. Gray N and Wickens M (1998) Control of translation initiation in animals. Annu. Rev. Cell Dev. Biol. 14: 399-458
65. Sachs AB (2000) Physical and functional interactions between the mRNA cap structure and the poly(A) tail In Translational Control of Gene Expression Sonenberg N, Hershey JWB and Mathews MB (eds) (New York: Cold Spring Harbor Laboratory Press) pp. 447-465
66. Bi X and Goss DJ (2000) Wheat germ poly(A)-binding protein increases the ATPase and the RNA helicase activity of translation initiation factors eIF4A, eIF4B, and eIF-iso4F. J. Biol. Chem. 275: 17740-17746
67. Haghighat A and Sonenberg N (1997) eIF4G dramatically enhances the binding of eIF4E to the mRNA 5′-cap structure. J. Biol. Chem. 272: 21677-21680
68. Raught B, Gingras AC, Gygi SP, Imataka H, Morino S, Gradi A, Aebersold R and Sonenberg N (2000) Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J. 19: 434-444
69. Morley SJ and Traugh JA (1990) Differential stimulation of phosphorylation of initiation factors eIF-4F, eIF-4B, eIF-3, and ribosomal protein S6 by insulin and phorbol esters. J. Biol. Chem. 265: 10611-10616
70. Morley SJ and Traugh JA (1993) Stimulation of translation in 3T3-L1 cells in response to insulin and phorbol ester is directly correlated with increased phosphate labelling of initiation factor (eIF-)4F and ribosomal protein S6. Biochimie 75: 985-989
71. Morley SJ and Pain VM (1995) Hormone-induced meiotic maturation in Xenopus oocytes occurs independently of p70s6k activation and is associated with enhanced initiation factor (eIF)-4F phosphorylation and complex formation. J. Cell Sci. 108: 1751-1760
72. Morley SJ and Pain VM (1995) Translational regulation during activation of porcine peripheral blood lymphocytes: association and phosphorylation of the alpha and gamma subunits of the initiation factor complex eIF-4F. Biochem. J. 312: 627-635
73. Fraser CS, Pain VM and Morley SJ (1999) The association of initiation factor 4F with poly(A)-binding protein is enhanced in serum-stimulated Xenopus kidney cells. J. Biol. Chem. 274: 196-204
74. Pyronnet S, Dostie J and Sonenberg N (2001) Suppression of cap-dependent translation in mitosis. Genes Dev. 15: 2083-2093
75. Qin H, Raught B, Sonenberg N, Goldstein EG and Edelman AM (2003) Phosphorylation screening identifies translational initiation factor 4GII as an intracellular target of Ca(2+)/calmodulin-dependent protein kinase I. J. Biol. Chem. 278: 48570-48579
76. Browning KS, Gallie DR, Hershey JW, Hinnebusch AG, Maitra U, Merrick WC and Norbury C (2001) Unified nomenclature for the subunits of eukaryotic initiation factor 3. Trends Biochem. Sci. 26: 284
77. Fraser CS, Lee JY, Mayeur GL, Bushell M, Doudna JA and Hershey JW (2004) The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40S ribosomal subunits in vitro. J. Biol. Chem. 279: 8946-8956
78. Deckwerth TL and Johnson EM (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123: 1207-1222
79. Zhou BB, Li HL, Yuan JY and Kirschner MW (1998) Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cell lines. Proc. Natl. Acad. Sci. USA 95: 6785-6790
80. Scott CE and Adebodun F (1999) 13C-NMR investigation of protein synthesis during apoptosis in human leukemic cell lines. J. Cell. Physiol. 181: 147-152
81. Morley SJ, McKendrick L and Bushell M (1998) Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through p38 mitogen-activated protein (MAP) kinase. FEBS Lett. 438: 41-48
82. Morley SJ, Jeffrey I, Bushell M, Pain VM and Clemens MJ (2000) Differential requirements for caspase-8 activity in the mechanism of phosphorylation of eIF2alpha, cleavage of eIF4GI and signaling events associated with the inhibition of protein synthesis in apoptotic Jurkat T cells. FEBS Lett. 477: 229-236
83. Jeffrey IW, Bushell M, Tilleray VJ, Morley SJ and Clemens MJ (2002) Inhibition of protein synthesis in apoptosis: differential requirements by the tumour necrosis factor α family and a DNA damaging agent for caspases and the double-stranded RNA-dependent protein kinase. Cancer Res. 62: 2272-2280
84. Donze O, Deng J, Curran J, Sladek R, Picard D and Sonenberg N (2004) The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 23: 564-571
85. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ, Eckmann L, Guiney DG and Karin M (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345
86. Gong B and Almasan A (2000) Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res. 60: 5754-5760
87. Clodi K, Wimmer D, Li Y, Goodwin R, Jaeger U, Mann G, Gadner H and Younes A (2000) Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells. Br. J. Haematol. 111: 580-586
88. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C and Gronemeyer H (2001) Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat. Med. 7: 680-686
89. Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K and Nakazawa S (2003) TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells. Blood 101: 3658-3667
90. Jones DT, Ganeshaguru K, Mitchell WA, Foroni L, Baker RJ, Prentice HG, Mehta AB and Wickremasinghe RG (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br. J. Haematol. 121: 713-720
91. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5: 157-163
92. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104: 155-162
93. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588
94. Bratton SB, MacFarlane M, Cain K and Cohen GM (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp. Cell Res. 256: 27-33
95. Peter ME and Krammer PH (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10: 26-35
96. Saelens X, Kalai M and Vandenabeele P (2001) Translation inhibition in apoptosis - caspase-dependent PKR activation and eIF2-α phosphorylation. J. Biol. Chem. 276: 41620-41628
97. Marissen WE, Guo Y, Thomas AAM, Matts RL and Lloyd RE (2000) Identification of caspase 3-mediated cleavage and functional alteration of eukaryotic initiation factor 2α in apoptosis. J. Biol. Chem. 275: 9314-9323
98. Satoh S, Hijikata M, Handa H and Shimotohno K (1999) Caspase-mediated cleavage of eukaryotic translation initiation factor subunit 2alpha. Biochem J. 342: 65-70
99. Clemens MJ, Bushell M and Morley SJ (1998) Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17: 2921-2931
100. Bushell M, Wood W, Jänicke RU, Clemens MJ and Morley SJ (1999) Caspase-3 is necessary and sufficient for cleavage of protein eukaryotic initiation factor 4G during apoptosis. FEBS Lett. 451: 332-336
101. Bushell M, Wood W, Clemens MJ and Morley SJ (2000) Changes in integrity and association of eukaryotic protein synthesis initiation factors during apoptosis. Eur. J. Biochem. 267: 1083-1091
102. Bushell M, Poncet D, Marissen WE, Flotow H, Lloyd RE, Clemens MJ and Morley SJ (2000) Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis in lymphoma cells: characterisation of an internal fragment generated by caspase-3-mediated cleavage. Cell Death Differ. 7: 628-636
103. Marissen WE and Lloyd RE (1998) Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol. Cell. Biol. 18: 7565-7574
104. Marissen WE, Gradi A, Sonenberg N and Lloyd RE (2000) Cleavage of eukaryotic translation initiation factor 4GII correlates with translation inhibition during apoptosis. Cell Death Differ. 7: 1234-1243
105. Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane M and Willis AE (2000) c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol. Cell. Biol. 20: 1162-1169
106. Gradi A, Imataka H, Svitkin YV, Rom E, Raught B, Morino S and Sonenberg N (1998) A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell. Biol. 18: 334-342
107. Marissen WE, Triyoso D, Younan P and Lloyd RE (2004) Degradation of poly(A) binding protein in apoptotic cells and linkage to translation regulation. Apoptosis 9: 67-75
108. Ventoso I, Blanco R, Perales C and Carrasco L (2001) HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc. Natl. Acad. Sci. USA 98: 12966-12971
109. Ohlmann T, Prevot D, Decimo D, Roux F, Garin J, Morley SJ and Darlix JL (2002) In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J. Mol. Biol. 318: 9-20
110. Morino S, Imataka H, Svitkin YV, Pestova TV and Sonenberg N (2000) Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region. Mol. Cell. Biol. 20: 468-477
111. Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R and Sonenberg N (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15: 2852-2864
112. Gingras AC, Raught B and Sonenberg N (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15: 807-826
113. Raught B, Gingras AC and Sonenberg N (2001) The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA 98: 7037-7044
114. Ly C, Arechiga AF, Melo JV, Walsh CM and Ong ST (2003) Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin. Cancer Res. 63: 5716-5722
115. Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X, Harwood FC and Houghton PJ (2002) 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin. J. Biol. Chem. 277: 13907-13917
116. Mita MM, Mita A and Rowinsky EK (2003) The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol. Ther. 2: S169-77
117. Sawyers CL (2003) Will mTOR inhibitors make it as cancer drugs? Cancer Cell. 4: 343-348
118. Hidalgo M and Rowinsky EK (2000) The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19: 6680-6686
119. Salaun P, Pyronnet S, Morales J, Mulner-Lorillon O, Belle R, Sonenberg N and Cormier P (2003) eIF4E/4E-BP dissociation and 4E-BP degradation in the first mitotic division of the sea urchin embryo. Dev. Biol. 255: 428-439
120. Karin M and Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18: 621-663
121. Almond JB and Cohen GM (2002) The proteasome: a novel target for cancer chemotherapy. Leukemia 16: 433-443
122. Aberle H, Bauer A, Stappert J, Kispert A and Kemler R (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16: 3797-3804
123. Chernov MV, Bean LJ, Lerner N and Stark GR (2001) Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation. J. Biol. Chem. 276: 31819-31824
124. Tee AR and Proud CG (2000) DNA-damaging agents cause inactivation of translational regulators linked to mTOR signaling. Oncogene 19: 3021-3031
125. Tee AR and Proud CG (2001) Staurosporine inhibits phosphorylation of translational regulators linked to mTOR. Cell Death Differ. 8: 841-849
126. Tee AR and Proud CG (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol. Cell. Biol. 22: 1674-1683
127. Methot N, Song MS and Sonenberg N (1996) A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3. Mol. Cell. Biol. 16: 5328-5334
128. Block KL, Vornlocher HP and Hershey JW (1998) Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3. J. Biol. Chem. 273: 31901-31908
129. Valasek L, Phan L, Schoenfeld LW, Valaskova V and Hinnebusch AG (2001) Related eIF3 subunits TIF32 and HCR1 interact with an RNA recognition motif in PRT1 required for eIF3 integrity and ribosome binding. EMBO J. 20: 891-904
130. Imataka H, Olsen HS and Sonenberg N (1997) A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J. 16: 817-825
131. Levy-Strumpf N, Deiss LP, Berissi H and Kimchi A (1997) DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol. Cell. Biol. 17: 1615-1625
132. Yamanaka S, Poksay KS, Arnold KS and Innerarity TL (1997) A novel translational repressor mRNA is edited extensively in livers containing tumours caused by the trans-gene expression of the apoB mRNA-editing enzyme. Genes Dev. 11: 321-333
133. Yamanaka S, Zhang XY, Maeda M, Miura K, Wang S, Farese Jr RV, Iwao H and Innerarity TL (2000) Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. EMBO J. 19: 5533-5541
134. Henis-Korenblit S, Levy Strumpf N, Goldstaub D and Kimchi A (2000) A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation. Mol. Cell. Biol. 20: 496-506
135. Rutjes SA, Utz PJ, van der Heijden A, Broekhuis C, van Venrooij WJ and Pruijn GJ (1999) The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ. 6: 976-986
136. Ayukawa K, Taniguchi S, Masumoto J, Hashimoto S, Sarvotham H, Hara A, Aoyama T and Sagara J (2000) La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis. J. Biol. Chem. 275: 34465-34470
137. Meerovitch K, Svitkin YV, Lee HS, Lejbkowicz F, Kenan DJ, Chan EK, Agol VI, Keene JD and Sonenberg N (1993) La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67: 3798-3807
138. James MC, Jeffrey IW, Pruijn GJ, Thijssen JP and Clemens MJ (1999) Translational control by the La antigen. Structure requirements for rescue of the double-stranded RNA-mediated inhibition of protein synthesis. Eur. J. Biochem. 266: 151-162
139. Xiao Q, Sharp TV, Jeffrey IW, James MC, Pruijn GJ, van Venrooij WJ and Clemens MJ (1994) The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res. 22: 2512-2518
140. Orton KC, Ling J, Waskiewicz AJ, Cooper JA, Merrick WC, Korneeva NL, Rhoads RE, Sonenberg N and Traugh JA (2004) Phosphorylation of Mnk1 by caspase-activated Pak2/gamma-PAK inhibits phosphorylation and interaction of eIF4G with Mnk. J. Biol. Chem. 279: 38649-38657
141. Morley SJ and Pain VM (2001) Proteasome inhibitors and immunosuppressive drugs promote the cleavage of eIF4GI and eIF4GII by caspase-8-independent mechanisms in Jurkat T cell lines. FEBS Lett. 503: 206-212
142. Del Prete MJ, Robles MS, Guao A, Martinez-A C, Izquierdo M and Garcia-Sanz JA (2002) Degradation of cellular mRNA is a general early apoptosis-induced event. FASEB J. 16: 2003-2005
143. Bushell M, Stoneley M, Sarnow P and Willis AE (2004) Translation inhibition during the induction of apoptosis: RNA or protein degradation? Biochem. Soc. Trans. 32: 606-610
144. King KL, Jewell CM, Bortner CD and Cidlowski JA (2000) 28S ribosome degradation in lymphoid cell apoptosis: evidence for caspase and Bcl-2-dependent and -independent pathways. Cell Death Differ. 7: 994-1001
145. Proud CG (2001) Regulation of eukaryotic initiation factor eIF2B. Prog. Mol. Subcell. Biol. 26: 95-114
146. Hinnebusch AG (1997) Translational regulation of yeast GCN4 - a window on factors that control initiator-tRNA binding to the ribosome. J. Biol. Chem. 272: 21661-21664
147. Lu PD, Harding HP and Ron D (2004) Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J. Cell Biol. 167: 27-33
148. Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T and Sonenberg N (1999) Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18: 270-279
149. De Gregorio E, Preiss T and Hentze MW (1999) Translation driven by an eIF4G core domain in vivo. EMBO J. 18: 4865-4874
150. Stoneley M, Paulin FEM, Le Quesne JPC, Chappell SA and Willis AE (1998) C-Myc 5-pm untranslated region contains an internal ribosome entry segment. Oncogene 16: 423-428
151. Stoneley M, Subkhankulova T, Le Quesne JPC, Coldwell MJ, Jopling CL, Belsham GJ and Willis AE (2000) Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment. Nucleic Acids Res. 28: 687-694
152. Hann SR and Eisenman RN (1984) Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4: 2486-2497
153. West MJ, Stoneley M and Willis AE (1998) Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway. Oncogene 17: 769-780
154. Holcik M, Lefebvre C, Yeh C, Chow T and Korneluk RG (1999) A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat. Cell Biol. 1: 190-192
155. Holcik M, Yeh C, Korneluk RG and Chow T (2000) Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19: 4174-4177
156. Carter MS and Sarnow P (2000) Distinct mRNAs that encode La autoantigen are differentially expressed and contain internal ribosome entry sites. J. Biol. Chem. 275: 28301-28307
157. Nevins TA, Harder ZM, Korneluk RG and Holcik M (2003) Distinct regulation of internal ribosome entry site-mediated translation following cellular stress is mediated by apoptotic fragments of eIF4G translation initiation factor family members eIF4GI and p97/DAP5/NAT1. J. Biol. Chem. 278: 3572-3579
158. Coldwell MJ, Hashemzadeh-Bonehi L, Hinton TM, Morley SJ and Pain VM (2004) Expression of fragments of translation initiation factor eIF4GI reveals a nuclear localisation signal within the N-terminal apoptotic cleavage fragment N-FAG. J. Cell Sci. 117: 2545-2555
159. Henis-Korenblit S, Shani G, Sines T, Marash L, Shohat G and Kimchi A (2002) The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc. Natl. Acad. Sci. USA 99: 5400-5405